Carcinoembryonic antigen

From Libre Pathology
Revision as of 12:18, 5 August 2016 by Michael (talk | contribs) (→‎Positive)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
CEA immunostaining in C-cell hyperplasia. (WC)

Carcinoembryonic antigen, abbreviated CEA, is set of glycoproteins present during fetal development and associated with the gastrointestinal tract.

In pathology, they are associated with gastrointestinal tract tumours; however, may be seen in other tumours.

Monoclonal & polyclonal

  • Several different types of CEA antibodies are available.

Broadly speaking they are divided into:

  • CEA-p = polyclonal CEA antibody.
  • CEA-m = monocloncal CEA antibody.

The staining is dependent on the specific antibody,[1] as is generally true.

Positive

See also

References

  1. Sheahan, K.; O'Brien, MJ.; Burke, B.; Dervan, PA.; O'Keane, JC.; Gottlieb, LS.; Zamcheck, N. (Aug 1990). "Differential reactivities of carcinoembryonic antigen (CEA) and CEA-related monoclonal and polyclonal antibodies in common epithelial malignancies.". Am J Clin Pathol 94 (2): 157-64. PMID 1695478.
  2. McCluggage, WG.; Sumathi, VP.; McBride, HA.; Patterson, A. (Jan 2002). "A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas.". Int J Gynecol Pathol 21 (1): 11-5. PMID 11781517.